# Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

> **NCT00956761** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 63 (actual)

## Conditions studied

- Seasonal Influenza

## Interventions

- **BIOLOGICAL:** Seasonal Influenza Vaccine (MF59C.1)

## Key facts

- **NCT ID:** NCT00956761
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2016-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956761, "Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00956761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*